VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2020 | Significance of oral hypomethylating agents

Amer Zeidan, MBBS, MHS, of Yale University and Yale Cancer Center, New Haven, CT, highlights the importance of the development of oral hypomethylating agents to improve patient compliance and outcomes. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter